Moraxella catarrhalis (Frosch and Kolle) Bovre (ATCC® 43617)

Strain Designations: 1908  /  Type Strain: no  /  Biosafety Level: 2

Deposited As Branhamella catarrhalis (Frosch and Kolle) Catlin
Strain Designations 1908
Application
Produces beta-lactamase BRO-2
Produces beta-lactamases beta-lactamase, lactamase
Susceptibility testing
Isolation
Transtracheal aspirate from coal miner with chronic bronchitis
Type Strain no
Biosafety Level 2
Product Format freeze-dried
Preceptrol® no
Type Strain no
Medium Medium 44: Brain Heart Infusion Agar/Broth
Medium 814: GC Agar/Broth Medium
Growth Conditions
Temperature: 37°C
Atmosphere: 5% CO2
Name of Depositor DR Nash
Chain of Custody
ATCC <-- DR Nash <-- C Reading <-- G Ninane
Isolation
Transtracheal aspirate from coal miner with chronic bronchitis
References

Farmer T, Reading C. beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob. Agents Chemother. 21: 506-508, 1982. PubMed: 6980625

Wallace RJ Jr., et al. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrob. Agents Chemother. 33: 1845-1854, 1989. PubMed: 2514622

Medical microbiology--Susceptibility testing of microbial pathogens to antimicrobial agents -- Part 82: Microdilution; Special requirements for testing of fastidious bacteria. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58940-82: 2002, 2002

Cross References

Nucleotide (GenBank) : Z54181 M.catarrhalis bla gene for BRO-2.